case_images: PMC2648950_01
case_images: Patient 1.
case_images: 1757-1626-2-19-1.jpg
case_images: PMC2648950_01_1757-1626-2-19-1.jpg
case_images: F1
case_images: Sensorineural hearing impairment was noted at 15 years of age and type 2 diabetes mellitus was diagnosed at 16 years of age (Figure 1).
case_images: Patient 1. Magnetic resonance imaging - morphologic appearance suggesting "empty sella".
case_images: 1757-1626-2-19-2.jpg
case_images: PMC2648950_01_1757-1626-2-19-2.jpg
case_images: F2
case_images: The MRI study of the diencephalic and pituitary region was suggestive for the diagnosis of empty sella (Figure 2).
case_images: Patient 2. Normal MRI study of the diencephalic and pituitary region.
case_images: 1757-1626-2-19-3.jpg
case_images: PMC2648950_01_1757-1626-2-19-3.jpg
case_images: F3
case_images: DEXA body composition analysis. Patient 2. Height/Weight: 167 cm/120 kg. Sex/Etnic: Female/White. Total region = 1,158 g/cm2 BMD1
case_images: 1757-1626-2-19-4.jpg
case_images: PMC2648950_01_1757-1626-2-19-4.jpg
case_images: F4
case_images: We used Re-GH in this patient for 12 consecutive months, in a dose of 0,25 mg/day, with very good results: the total body fat mass decreased after one year, most significant in visceral trunk location as revealed by DEXA body composition, the bone density increased with 5% after 6 months (Figure 4).
case_images: Patient 2. Echocardiography: left ventricular mass index, fractional shortening and fiber shortening velocity improved after 12 month of low-dose therapy with Re-GH.
case_images: 1757-1626-2-19-5.jpg
case_images: PMC2648950_01_1757-1626-2-19-5.jpg
case_images: F5
case_images: Echocardiography has shown that left ventricular mass index, fractional shortening and fiber shortening velocity improved after 12 month of low-dose therapy (Figure 5).
case_images: Patient 3.
case_images: 1757-1626-2-19-6.jpg
case_images: PMC2648950_01_1757-1626-2-19-6.jpg
case_images: F6